Novavax is trading 5.3% down today at $8.44 amid continued profit-taking and broader weakness across high-beta biotech names.
- The stock is extending a multi-day slide following a significant biotech rally last week.
- The move aligns with a broader industry pullback, with the sector ETF XBI down approximately 2.5%.
- There are no new company-specific catalysts or news items reported for the stock today.